최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.37 no.3, 2016년, pp.529 - 538
최은솔 (경희대학교 대학원 임상한의학과) , 김하연 (경희대학교 대학원 임상한의학과) , 배정한 (경희대학교 대학원 임상한의학과) , 장은경 (경희대학교 대학원 임상한의학과) , 김영철 (경희대학교 대학원 임상한의학과) , 이장훈 (경희대학교 대학원 임상한의학과)
Objectives: The purpose of this case study is to report the efficacy and safety of treatment with Korean medicine of a patient with HBeAg-positive chronic viral hepatitis B.Methods: The patient took Korean medicine (mainly Injinchunggan-tang-gamibang) from July 20th, 2010, to March 14th, 2016, witho...
Park CH, Lee SM, Kim TO, Kim DU, Jung WJ, Kim GH, et al. Treatment of solitary extramedullary plasmacytoma of the stomach with endoscopic submucosal dissection. Gut Liver 2009;3:334-7.
Song IS, Kim CY. Seasonal and annual variations on occurrence of HBsAg and acquisition of anti-HBs in Korea. Korean J Intern Med 1979;22:1007-15.
Korea Centers for Disease Control and Prevention. 2006 Disease Control White Paper. Korea Centers for Disease Control and Prevention. 2007;144.
Lee BS, Cho YK, Jeong SH, Lee JH, Lee D, Park NH, et al. Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs. J Med Virol 2013;85:1327-33.
Ministry of Helalth & Welfare KCfDCaP. The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2010. Health Examination. Ministry of Helalth & Welfare 2012.
Chae HB, Kim JH, Kim JK, Yim HJ. Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol 2009;15(Suppl 6):S13-S24.
Cheon JH, Park JW, Park KW, Kim YI, Kim SH, Lee WJ, et al. The clinical report of 1,078 cases of hepatocellular carcinomas: National Cancer Center experience. Korean J Hepatol 2004;10:288-97.
Kim SR, Kudo M, Hino O, Han KH, Chung YH, Lee HS; Organizing Committee of Japan-Korea Liver Symposium. Epidemiology of hepatocellular carcinoma in Japan and Korea. Oncology 2008;75(Suppl 1):13-6.
Bae SH, Yoon SK, Jang JW, Kim CW, Nam SW, Choi JY, et al. Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea. J Korean Med Sci 2005;20:816-20.
Kim H, Jee YM, Song BC, Shin JW, Yang SH, Mun HS, et al. Molecular epidemiology of hepatitis B virus (HBV) genotypes and serotypes in patients with chronic HBV infection in Korea. Intervirology 2007;50:52-7.
Lee JM, Ahn SH, Chang HY, Shin JE, Kim DY, Sim MK, et al. Reappraisal of HBV genotypes and clinical significance in Koreans using MALDI-TOF mass spectrometry. Korean J Hepatol 2004;10:260-70.
Livingston SE, Simonetti JP, Bulkow LR, Homan CE, Snowball MM, Cagle HH, et al Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 2007;133:1452-7.
The Korean Association for the Study of the Liver. 2015 Chronic Hepatitis B Clinical Practive Guideline. Seoul: Publishing & Printing Co. Jin; 2015, p. 32-72.
Manns MP, Akarca US, Chang TT, Sievert W, Yoon SK, Tsai N, et al. Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901. Expert Opin Drug Saf 2012;11:361-8.
Koteiche HA, Reeves MD, McHaourab HS. Structure of the substrate binding pocket of the multidrug transporter EmrE: site-directed spin labeling of transmembrane segment 1. Biochemistry 2003;42:6099-105.
Gupta SK. Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system. AIDS Patient Care STDS 2008;22:99-103.
Gish RG, Lok AS, Chang TT, de Man RA, Gadano A, Sollano J, et al. Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. Gastroenterology 2007;133:1437-44.
Hong JW, et al. Study of Korean Medicine Liver System. 6 th edition. Seoul: Publishing & Printing Co. Nado; 2015, p. 65-138, 262-305.
Kang KT, Lee JH, Woo HJ. The Effect of Inchinchunggantang-derivative on Mouse Virus Hepatitis(MHV-2M) and Water Immersion Stress. Journal of Kyung Hee University Graduate School 1997;20(2):133-50.
Park YJ, Kim YC, Lee JH, Woo HJ. The Effect of Injinchunggantang-derivative on Proliferation of Hepatocyte. J Korean Med 1998;19(1):145-64.
Hong SH, Lee JH, Woo HJ. The Effects of Injinchunggantang-derivative on Cell Viability, Cell Cycle Progression and Apoptosis of Hepatocytes. J Korean Med 1998;19(2):337-72.
Ko H, Lee JH, Woo HJ. The Effects of 5 kinds of Injinsaryung-San fractions on Cell Viablity, Cell Cycle Progression and Fas-mediated Apoptosis of HepG2 Cells. J Korean Med 2000;21(3):174-85.
Lee JH, Lee JH, Woo HJ. Effects of Five Fractions of Artemisia capillaris THUNB on TGFβ1-induced Apotosis in HepG2 Cells. J Korean Med 2000;20(1):53-61.
Shin SM, Kim YC, Lee JH, Woo HJ. Effect of Injin Fraction on Hepatic Fibrosis induced by TGF-β1. J Korean Med 2001;22(3):141-55.
Sim JG, Seo JK, Suh SJ. Prevalence and its changes of hepatitis B viral markers from 1988 to 1993 in Korean children. J Korean Pediatr 1995;38:1535-9.
Shim JH, Lee HC, Kim KM, Lim YS, Chung YH, Lee YS, et al. Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis. J Hepatol 2010;52:176-82.
Liaw YF, Sheen IS, Lee CM, Akarca US, Papatheodoridis GV, Suet-Hing Wong F, et al. Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease. Hepatology 2011;53:62-72.
Osborn M. Safety and efficacy of entecavir for the treatment of chronic hepatitis B. Infect Drug Resist 2011;4:55-64.
Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, et al. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy. Hepatology 2009;49:1503-14.
Manns MP, Akarca US, Chang TT, Sievert W, Yoon SK, Tsai N, et al. Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901. Expert Opin Drug Saf 2012;11:361-8.
YJ Jung, JH Lee, SH Kim, CW Kim, JE Lee, YC Kim, HJ Woo. Five Cases of Patients Treated with Injinchunggan-tang for Liver Cirrhosis and Chronic Hepatitis B. Korean J Orient Int Med 2006;27(4):1014-26.
Kim CG. Study on the Maternal Serum Alpha-Fetoprotein During Pregnancy. Obstetrics & Gynecology Science 1986;29(9):1240-55.
Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130:678-86.
Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73.
Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology. 2002;35:1522-7.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.